Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease-Reference-Cited by-同舟云学术

Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease

Published:2023-10-01 Issue:10 Volume:27 Page:729-741
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Visca D.¹,Centis R.²,Pontali E.³,Zampogna E.⁴,Russell A.-M.⁵,Migliori G. B.²,Andrejak C.⁶,Aro M.⁷,Bayram H.⁸,Berkani K.⁹,Bruchfeld J.¹⁰,Chakaya J. M.¹¹,Chorostowska-Wynimko J.¹²,Crestani B.¹³,Dalcolmo M. P.¹⁴,D’Ambrosio L.¹⁵,Dinh-Xuan A-T.¹⁶,Duong-Quy S.¹⁷,Fernandes C.¹⁸,García-García J.-M.¹⁹,de Melo Kawassaki A²⁰,Carrozzi L.²¹,Martinez-Garcia M. A.²²,Martins P. Carreiro²³,Mirsaeidi M.²⁴,Mohammad Y.²⁵,Naidoo R. N.²⁶,Neuparth N.²³,Sese L.²⁷,Silva D. R.²⁸,Solovic I.²⁹,Sooronbaev T. M.³⁰,Spanevello A.¹,Sverzellati N.³¹,Tanno L.³²,Tiberi S.³³,Vasankari T.³⁴,Vasarmidi E.³⁵,Vitacca M.³⁶,Annesi-Maesano I.³²

Affiliation:

1. Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici (ICS) Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Department of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese

2. Respiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate

3. Department of Infectious Diseases, Galliera Hospital, Genoa, Italy

4. Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici (ICS) Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate

5. Faculty of Health and Life Sciences, University of Exeter, Exeter, Royal Devon University Hospitals NHS Trust, Exeter, North Bristol NHS Trust, Bristol, UK

6. Respiratory Department, Centre Hospitalier Universitaire Amiens Picardie, Amiens, Unité de Recherche 4294, Agents Infectieux, Résistance et Chimiothérapie, Picardie Jules Verne University, Amiens, GREPI (Group pour la Recherche et enseignement en pneumo-infectiologie) Work group of French society of respiratory diseases, Paris, France

7. Finnish Lung Health Association (FILHA), Helsinki, Finland

8. Department of Pulmonary Medicine, Koc University Research Center for Translational Medicine, Koc University School of Medicine, Istanbul, Turkey

9. Pierre de Soleil Clinic, Respiratory Rehabilitation, Vetraz Monthoux, France

10. Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Division of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

11. Department of Medicine, Therapeutics and Dermatology, Kenyatta University, Nairobi, Kenya, Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK

12. Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland

13. Université Paris Cité, Physiopathologie et épidémiologie des maladies respiratoires, Institut national de la santé et de la recherche médicale (INSERM), Paris, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Bichat, Service de Pneumologie A, FHU APOLLO, Paris, France

14. Hélio Fraga Reference Center, Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil

15. Public Health Consulting Group, Lugano, Switzerland

16. Service de Physiologie-Explorations Fonctionnelles, APHP, Hôpital Cochin, Université Paris Cité, Paris, France

17. Respiratory Department, Lam Dong Medical College, Dalat, Vietnam

18. Heart Institute, Cardio-pulmonology Department, University of Sao Paulo, Sao Paulo, SP, Brazil

19. Tuberculosis Research Programme (PII-TB), Sociedad Española de Neumología y Cirugía Torácica, Barcelona, Spain

20. Serviço de Pneumologia, Instituto do Câncer do Estado de São Paulo (ICESP) e do ambulatÓrio de Doenças Pulmonares Intersticiais, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brazil

21. Department of Surgical, Medical, and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Pulmonary Unit, Cardiothoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy

22. Respiratory Department, University and Polytechnic La Fe Hospital, Valencia, Centro de InvestigaciÓn Biomédica en Red, Respiratory Disorders, Madrid, Spain

23. Allergy and Clinical Immunology Department, Dona Estefânia Hospital, Centro Hospitalar Universitário de Lisboa Central, Lisbon, NOVA Medical School-Comprehensive Health Research Center, Lisbon, Portugal

24. Division of Pulmonary and Critical Care, University of Florida, Jacksonville, FL, USA

25. Al Sham private University, Faculty of Medicine and Pharmacy, Damascus and Latakia, Centre for Research on Chronic Respiratory Diseases, Tishreen University, Lattakia, Syria

26. Discipline of Occupational and Environmental Health, University of KwaZulu-Natal, Durban, South Africa

27. Department of Physiology and Functional Explorations, Hôpital Avicenne, INSERM, Unité mixte de recherche 1272 Hypoxia and the Lung, Université Sorbonne Paris Nord, Bobigny, Department of Pneumology, Centre Constitutif de référence des maladies pulmonaires rares, Hôpital Avicenne, Bobigny, France

28. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil

29. National Institute for TB, Lund Diseases and Thoracic Surgery, Vysne Hagy, Catholic University, Ruzomberok, Slovakia

30. Department of Respiratory Medicine, National Center for Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

31. Department of Medicine and Surgery, University of Parma, Parma, Italy

32. Institut Desbrest of Epidemiology and Santé Publique, INSERM & Montpellier University, Montpellier and Department of Allergic and Respiratory Diseases, Montpellier University Hospital, Montpellier, France

33. Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK

34. FILHA, Helsinki, University of Turku, Department of Pulmonary Diseases and Clinical Allergology, Turku, Finland

35. Department of Respiratory Medicine and Laboratory of Molecular and Cellular Pneumonology, School of Medicine, University of Crete, Heraklion, Greece

36. ICS Maugeri IRCCS, Respiratory Rehabilitation of the Institute of Lumezzane, Brescia, Italy

Abstract

BACKGROUND: The aim of these clinical standards is to provide guidance on ‘best practice’ care for the diagnosis, treatment and prevention of post-COVID-19 lung disease.METHODS: A panel of international experts representing scientific societies, associations and groups active in post-COVID-19 lung disease was identified; 45 completed a Delphi process. A 5-point Likert scale indicated level of agreement with the draft standards. The final version was approved by consensus (with 100% agreement).RESULTS: Four clinical standards were agreed for patients with a previous history of COVID-19: Standard 1, Patients with sequelae not explained by an alternative diagnosis should be evaluated for possible post-COVID-19 lung disease; Standard 2, Patients with lung function impairment, reduced exercise tolerance, reduced quality of life (QoL) or other relevant signs or ongoing symptoms ≥4 weeks after the onset of first symptoms should be evaluated for treatment and pulmonary rehabilitation (PR); Standard 3, The PR programme should be based on feasibility, effectiveness and cost-effectiveness criteria, organised according to local health services and tailored to an individual patient’s needs; and Standard 4, Each patient undergoing and completing PR should be evaluated to determine its effectiveness and have access to a counselling/health education session.CONCLUSION: This is the first consensus-based set of clinical standards for the diagnosis, treatment and prevention of post-COVID-19 lung disease. Our aim is to improve patient care and QoL by guiding clinicians, programme managers and public health officers in planning and implementing a PR programme to manage post-COVID-19 lung disease.

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatment;IJTLD OPEN;2024-03-01

2. Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious;The International Journal of Tuberculosis and Lung Disease;2024-02-01

3. Standards for clinical trials for treating TB;The International Journal of Tuberculosis and Lung Disease;2023-12-01

4. How is preterm birth working out: cardiopulmonary response to exercise in extreme prematurity;European Respiratory Journal;2023-11

5. Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort;European Respiratory Journal;2023-10-12